Immune-mediated neuropathy with Epstein-Barr virus-positive T-cell lymphoproliferative disease.
Autor(es): Hattori Takaaki; Arai Ayako; Yokota Takanori; Imadome Ken-Ichi; Tomimitsu Hiroyuki; Miura Osamu; Mizusawa Hidehiro
Resumo: A 47-year-old man with Epstein-Barr virus (EBV)-positive T/NK- cell lymphoproliferative disease (EBV-T/NK-LPD) developed acute-onset weakness. A nerve conduction study showed a conduction block in both the proximal and most distal segments. Although the patient's neuropathy transiently responded to intravenous immunoglobulin, it was progressive for at least 25 days until the start of prednisolone (PSL) administration, after which it remarkably improved. The neuropathy further improved after allogeneic bone marrow transplantation (BMT). The present patient's clinical course is not consistent with that of typical Guillain-Barré syndrome. This case suggests that EBV-T/NK-LPD can cause progressive immune-mediated neuropathy as a result of chronic EBV antigen presentation and can be treated with PSL and BMT.
Imprenta: Internal Medicine, v. 54, n. 1, p. 69-73, 2015
Identificador do objeto digital: 10.2169/internalmedicine.54.3173
Descritores: Guillain-Barre Syndrome - Cell ; Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Viral infections ; Guillain-Barre Syndrome - Virus
Data de publicação: 2015
